Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: An historical cohort analysis of the United States Renal Data System

Transplant Infectious Disease

Volumn 4, Issue 3, 2002, Pages 144-147

  Swanson, S J ^a,b   Kirk, A D ^c   Ko, C W ^d   Jones, C A ^e   Agodoa, L Y ^e   Abbott, K C ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Graft survival; HIV; Patient survival; Renal transplant

Indexed keywords

ADULT; ARTICLE; CADAVER KIDNEY; COHORT ANALYSIS; ETHNIC DIFFERENCE; FEMALE; GRAFT SURVIVAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTORY; HLA MATCHING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SEX RATIO; SURGICAL MORTALITY; SURVIVAL; UNITED STATES;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CADAVER; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HIV INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTRIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0036759542     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2002.01009.x     Document Type: Article

References (17)

1. Purgus R, Tamalet C, Poignard P, et al. Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient. Transplantation 1998: 66: 1384-1386.
2. Onwubalili JK, Obineche EN, Assuhaimi S, Bassiouni M. Outcome of bought living non-related donor kidneys followed up at a single centre. Transpl Int 1994: 7: 27-32.
3. The Living Non-Related Renal Transplant Study Group. Commercially motivated renal transplantation: Results in 540 patients transplanted in India. Clin Transplant 1997: 11: 536-544.
4. Kuo PC, Sotck PG. Transplantation in the HIV+ patient. Am J Transplant 2001: 1: 13-17.
5. Wickware P. $1 million study renews HIV/transplant research. Nat Med 2000: 6: 365.
6. http://www.usrds.org.
7. Tsakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE. Transplantation in HIV+ patients. Transplantation 1990: 49: 354-358.
8. Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH. Human immunodeficiency virus infection in patients with solid organ transplants: Report of five cases and review. Rev Inf Dis 1991: 13: 537-547.
9. Rolland M, Carlson L, Tomlanovich S, et al. Renal transplantation HIV+ patients. Am J Transplant 2001: 1 (Supp 1): 164 (Abstract #114).
10. Shahinian V, Rajaraman S, Borucki M, Grady J, Hollander WM, Ahuja TS. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis 2000: 35: 884-888.
11. Humphreys MH. Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 1995: 48: 311-320.
12. Rao TK. Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int Suppl 1991: 35: S13-S18.
13. D'Agati V, Appel GB. HIV infection and the kidney. J Am Soc Nephrol 1997: 8: 138-152.
14. Abbott KC, Hypolite IO, Welch PG, Agodoa LY. Human immunodeficiency virus/acquired immunodeficiency syndrome associated nephropathy at end stage renal disease in the United States: Patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 2001: 14: 377-383.
15. Swanson SJ, Hypolite IO, Agodoa LY, et al. Effect of donor factors on adult cadaveric renal transplantation. Am J Transplant 2002: 2: 68-75.
16. Chapuis AG, Paolo Rizzardi G, D'Agostino C, et al. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000: 6: 762-768.
17. Rizzardi GP, Vaccarezza M, Capiluppi B, Tambussi G, Lazzarin A, Pantaleo G. Cyclosporin A in combination with HAART in primary HIV-1 infection. J Biol Regul Homeost Agents 2000: 14: 79-81.